Doxycycline postexposure prophylaxis reduces the incidence o

1. In this randomized trial, postexposure prophylactic doxycycline significantly reduced the incidence of sexually transmitted infections (STIs) in men who have sex with men (MSM) and transgender women. 2. Postexposure prophylaxis with doxycycline was not associated with an increased risk of serious adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown: MSM and transgender women

Related Keywords

, Minute Medicine Inc , Rating Level , Confidence Interval , Doxycycline , Shiv , Human Immunodeficiency Virus , Human Immunodeficiency Virus Hiv , Infectious Disease , Msm , Post Exposure Prophylaxis , Public Health , Sexually Transmitted Infections ,